SKIP TO MAIN CONTENT

Buprenorphine

Buprenorphine for the Treatment of Opioid Use Disorder training module (CDC)

Care Coordination

Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions from Multiple Prescribers and Overdose Risk

2022 CDC Clinical Practice Guideline

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

Recommendation 1

Recommendation 2

Recommendation 3

Recommendation 4

Recommendation 5

Recommendation 6

Recommendation 7

Recommendation 8

Recommendation 9

Recommendation 10

Recommendation 11

Recommendation 12

Clinical Practice Guideline at a Glance (CDC)

What's Different (CDC)

Motivational Interviewing

Motivational Interviewing training module (CDC)

Motivational Interviewing patient case (CDC)

Naloxone

Naloxone (CDC)

Naloxone Training (CDC)

Naloxone Fact Sheets (CDC)

Opioids

Opioids (CDC)

Opioid Use Disorder

Assessing and Addressing Opioid Use Disorder (OUD) training module (CDC)

Acute pain

Pain that is normally sudden in onset and time-limited (defined in the 2022 Clinical Practice Guideline as less than 1 month); and often caused by injury, trauma, or medical treatments such as surgery.¹

Care coordination

Deliberate organization of patient care activities and information sharing among all of the participants, such as clinicians, caregivers, and/or social workers, concerned with a patient's care to achieve safer and more effective care.²

Chronic pain

Pain that typically lasts longer than three months. Chronic pain can be the result of an underlying medical disease or condition, injury, medical treatment, inflammation, or unknown cause.¹

Opioid use disorder (OUD)

A problematic pattern of opioid use leading to clinically significant impairment or distress. A diagnosis is based on specific Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, such as unsuccessful efforts to cut down or control use, or use resulting in social problems and a failure to fulfill obligations at work, school, or home, among other criteria.³

Subacute pain

Pain with a duration of at least one month and up to three months.¹ Subacute pain can be the result of an underlying medical disease or condition, injury, medical treatment, inflammation, or unknown cause.

Psychosocial supports - Ancillary services to enhance a patient's overall functioning and well-being, including recovery support services, case management, housing, employment, and educational services.⁴

Tapering

The deliberate and gradual reduction of medication dosage over a period of time to provide the body with an opportunity to adjust to the decreasing dosage, thereby reducing the likelihood of withdrawal symptoms and other negative consequences associated with abrupt cessation of a medication. This process is often implemented for a variety of reasons, including, but not limited to, reducing the dosage of opioids to minimize side effects, or discontinuing the use of opioids completely.

 

¹ Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. (2022). MMWR Recommendations and Reports; 71(No. RR-3):1–95. DOI: http://dx.doi.org/10.15585/mmwr.rr7103a1

² Agency for Healthcare Research and Quality. (2018, August). Care Coordination. Retrieved September 6, 2022, from https://www.ahrq.gov/ncepcr/care/coordination.html

³ American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2013.

⁴ Treatment Improvement Protocol (TIP) Series 63: Medications for Opioid Use Disorder. (2021). Substance Abuse and Mental Health Services Administration. Publication No. PEP21-02-01-002. Retrieved September 6, 2022, from https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP21-02-01-002.pdf

(For  Review Only) Reset all vars debug only

 

Tapering Opioids

the module

Select Close Tutorial to exit.

Select Next to continue.